Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Downer EDI (DOW.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-02-16	5.38	6.50	Buy
2022-04-27	5.33	6.40	Buy
2022-11-08	4.85	6.15	Buy
2022-12-08	3.82	4.00	Neutral
2023-02-28	3.16	3.30	Neutral
2023-04-27	3.45	3.60	Neutral
2023-07-24	4.57	4.65	Neutral
2023-08-10	4.10	4.50	Neutral
2023-11-22	4.13	4.55	Neutral
2024-02-15	5.07	4.90	Neutral
2024-08-30	5.59	5.75	Neutral
2025-02-14	5.23	5.80	Neutral

Disclosures

Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.